KCT0000799已完成未知
Bioequivalence of Sam Chun Dang torasemide 5 mg in Korean subjects
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 55(Year)（—）
- 性别
- All
入选标准
- •1. Subjects between the ages of 19 and 55 years
- •2. No History of congenital or chronic disease
- •3. No clinically relevant abnormalities identified by laboratory test, including hematology, blood chemistry, and urinalysis
- •4. Female subject known to be negative for pregnant test
排除标准
- •1. Use of any drugs (Barbitals, alcohol) known to significantly induce or inhibit drug-metabolizing enzymes within 1 month prior to dosing
- •2. Received any drugs within 10 days before the study
- •3. Inappropriate subject for entry into this study in the judgement of the investigator
研究者
相似试验
已完成
不适用
Bioequivalence of Sam Chun Dang torasemide 20 mg in Korean subjectsKCT0000798Chonnam National University28
已完成
不适用
Bioequivalence of torasemide 5 mg in Korean subjectsKCT0000795Chonnam National University28
已完成
不适用
Bioequivalence of torasemide 10 mg in Korean subjectsKCT0000794Chonnam National University28
已完成
不适用
Bioequivalence study of Tamsulosin 0.4 mgIRCT20200623047902N4Sanamed pharma company18
招募中
不适用
Clinical study to compare the in vivo parameters of 2 Tamsulosin 0.4 mg ER Capsule formulationsIRCT20180620040164N28Cosar pharmaceutical Co.24